PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Nov-2024 Nyxoah Reports Third Quarter Financial and Operating Results Nyxoah SA.
06-Nov-2024 The MAP Group broadens their European market access platform by adding SKC to its portfolio of companies The MAP Group
06-Nov-2024 UK’s medicines manufacturing skills centre welcomes Budget’s £520 million for manufacturing but says the priority must be skills development Innovate UK / Resilience
06-Nov-2024 MHRA grants marketing authorisation to J&J’s bladder cancer therapy BALVERSA®▼ (erdafitinib) Johnson & Johnson
06-Nov-2024 Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024 Heidelberg Pharma
06-Nov-2024 Biosynth Names Matt Gunnison as CEO, Kieran Murphy Appointed as Chairman Biosynth
06-Nov-2024 Bespak and Orbia Fluor & Energy Materials unite to accelerate transition to climate-friendly inhalers Bespak
06-Nov-2024 Poolbeg Pharma plc to present POLB 001 pre-clinical study data at the 66th American Society of Hematology (ASH) Annual Meeting Poolbeg Pharma plc
06-Nov-2024 EDX MEDICAL SIGNS EXCLUSIVE PARTNERSHIP AGREEMENT TO PROVIDE ADVANCED TESTICULAR CANCER TEST EDX Medical Group plc
06-Nov-2024 Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Sanofi
06-Nov-2024 Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024 Heidelberg Pharma AG
06-Nov-2024 Asklepios places its first Social Schuldschein loan of EUR 500.0 million Asklepios Kliniken
06-Nov-2024 Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions Evotec SE
05-Nov-2024 Seaport Therapeutics Names Lauren White as Chief Financial Officer Seaport Therapeutics
05-Nov-2024 Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI Nxera Pharma
05-Nov-2024 Murugan Govindasamy Joins Boon Logic as Strategic Advisor Boon Logic
05-Nov-2024 CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 PharmaSGP Holding SE
05-Nov-2024 PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer PharmaSGP Holding SE
05-Nov-2024 Evotec Announces Sale of API Manufacturing Facility to Monacum Partners Evotec SE
05-Nov-2024 Spexis expects SIX to delist shares of Spexis on the SIX exchange imminently. Spexis AG